Renée Zindell
Boehringer Ingelheim (United States)(US)
Publications by Year
Research Areas
Cannabis and Cannabinoid Research, Pharmacological Receptor Mechanisms and Effects, Neurotransmitter Receptor Influence on Behavior, Protease and Inhibitor Mechanisms, Inflammatory mediators and NSAID effects
Most-Cited Works
- → Binding Site Elucidation of Hydantoin-Based Antagonists of LFA-1 Using Multidisciplinary Technologies: Evidence for the Allosteric Inhibition of a Protein−Protein Interaction(2001)131 cited
- → Trifluoromethyl group as a pharmacophore: Effect of replacing a CF3 group on binding and agonist activity of a glucocorticoid receptor ligand(2005)106 cited
- → Design and Synthesis of Dipeptide Nitriles as Reversible and Potent Cathepsin S Inhibitors(2002)83 cited
- → 5-Aminomethylbenzimidazoles as potent ITK antagonists(2009)45 cited
- → Quinol-4-ones as Steroid A-Ring Mimetics in Nonsteroidal Dissociated Glucocorticoid Agonists(2006)41 cited
- → Synthesis, SAR, and Series Evolution of Novel Oxadiazole-Containing 5-Lipoxygenase Activating Protein Inhibitors: Discovery of 2-[4-(3-{(R)-1-[4-(2-Amino-pyrimidin-5-yl)-phenyl]-1-cyclopropyl-ethyl}-[1,2,4]oxadiazol-5-yl)-pyrazol-1-yl]-N,N-dimethyl-acetamide (BI 665915)(2015)35 cited
- → Identification of dissociated non-steroidal glucocorticoid receptor agonists(2007)34 cited
- → Selective CB2 receptor agonists. Part 1: The identification of novel ligands through computer-aided drug design (CADD) approaches(2014)21 cited
- → Morpholine containing CB2 selective agonists(2009)19 cited
- → Aryl 1,4-diazepane compounds as potent and selective CB2 agonists: Optimization of drug-like properties and target independent parameters(2011)14 cited